Advances in antivirulence natural products targeting the suilysin of Streptococcus suis

Abstract

Streptococcus suis (S. suis) is an important zoonotic pathogen that can cause sepsis, meningitis and toxic shock syndrome and is a serious threat to public health. Conventional antibiotic therapy is facing an increasing problem of drug resistance, and antivirulence strategies targeting virulence factors provide a new direction for infection prevention and control. Natural products provide potential lead compounds for the development of novel antibacterial drugs. Suilysin (SLY), a key virulence factor, plays a key role in pathogenesis by disrupting host cell membranes, inducing excessive inflammatory responses and promoting blood‒brain barrier penetration. In this paper, we systematically review the progress of research on antivirulence natural products that target SLY, including flavonoids, bioflavonoids, flavonols, flavonolignans, isoflavonoids and alkaloids. These natural products can directly target SLY; combine antibacterial, anti-inflammatory and antioxidant effects; and are less likely to induce drug resistance. This review provides data support and references for the development of novel natural antimicrobial drugs and anti-infection strategies.

Keywords

Streptococcus suis / Suilysin / Antivirulence / Natural products

References

[1] Adnan M, Rasul A, Hussain G, Shah MA, Zahoor MK, Anwar H, Sarfraz I, Riaz A, Manzoor M, Adem Ş, Selamoglu Z. Ginkgetin: A natural biflavone with versatile pharmacological activities. Food and Chemical Toxicology, 2020, 145. 111642

[2] Alipieva K, Korkina L, Orhan IE, Georgiev MI. Verbascoside–a review of its occurrence, (bio)synthesis and pharmacological significance. Biotechnology Advances, 2014, 32(6): 1065-1076.

[3] Bakpatina-Batako MVP, Li K, Lacouture S, Cipolla L, Gianecini A, Prieto M, Gottschalk M, Fittipaldi N. Human Streptococcus suis Infections, South America, 1995–2024. Emerging Infectious Diseases, 2025, 31(7): 1277-1286.

[4] Balcha FB, Neja SA. CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics. Animal Diseases, 2023, 3(1. 4

[5] Banik K, Ranaware AM, Harsha C, Nitesh T, Girisa S, Deshpande V, Fan L, Nalawade SP, Sethi G, Kunnumakkara AB. Piceatannol: A natural stilbene for the prevention and treatment of cancer. Pharmacological Research, 2020, 153. 104635

[6] Berube BJ, Bubeck Wardenburg J. Staphylococcus aureus α-toxin: Nearly a century of intrigue. Toxins., 2013, 5(6): 1140-1166.

[7] Buroni S, Chiarelli LR. Antivirulence compounds: A future direction to overcome antibiotic resistance?. Future Microbiology, 2020, 15: 299-301.

[8] Cao P, Lin M, Chen Z, Zhang G, Lai XH, Wu X, Niu L. Identification and genomic analyses of a Streptococcus suis ST25 strain associated with the first human septicemia in mainland China. Heliyon, 2024, 10(15. e35456

[9] Chen S, Liu H, Wang S, Jiang H, Gao L, Wang L, Teng L, Wang C, Wang D. The neuroprotection of verbascoside in Alzheimer's disease mediated through mitigation of neuroinflammation via blocking NF-κB-p65 signaling. Nutrients, 2022, 14(7): 1417.

[10] Dalil D, Iranzadeh S, Kohansal S. Anticancer potential of cryptotanshinone on breast cancer treatment; A narrative review. Frontiers in Pharmacology, 2022, 13. 979634

[11] Dan VM, Varghese TS, Viswanathan G, Baby S. Ellipticine, its derivatives: Re-evaluation of clinical suitability with the aid of drug delivery systems. Current Cancer Drug Targets, 2020, 20(1): 33-46.

[12] Ding YY, Zhou H, Peng D, Zhang BQ, Zhang ZJ, Wang GH, Zhang SY, Wu ZR, Wang YR, Liu YQ. Antimicrobial activity of natural and semisynthetic carbazole alkaloids. European Journal of Medicinal Chemistry, 2023, 259. 115627

[13] Dong J, Qiu J, Wang J, Li H, Dai X, Zhang Y, Wang X, Tan W, Niu X, Deng X, Zhao S. Apigenin alleviates the symptoms of Staphylococcus aureus pneumonia by inhibiting the production of alpha-hemolysin. FEMS Microbiology Letters, 2013, 338(2): 124-131.

[14] Escaich S. Antivirulence as a new antibacterial approach for chemotherapy. Current Opinion in Chemical Biology, 2008, 12(4): 400-408.

[15] Estrela JM, Mena S, Obrador E, Benlloch M, Castellano G, Salvador R, Dellinger RW. Polyphenolic phytochemicals in cancer prevention and therapy: Bioavailability versus bioefficacy. Journal of Medicinal Chemistry, 2017, 60(23): 9413-9436.

[16] Fang G, Li X, Yang F, Huang T, Qiu C, Peng K, Wang Z, Yang Y, Lan C. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signaling pathway. Phytomedicine, 2023, 117. 154922

[17] Feder I, Chengappa MM, Fenwick B, Rider M, Staats J. Partial characterization of Streptococcus suis type 2 hemolysin. Journal of Clinical Microbiology, 1994, 32(5): 1256-1260.

[18] Fu YJ, Xu B, Huang SW, Luo X, Deng XL, Luo S, Liu C, Wang Q, Chen JY, Zhou L. Baicalin prevents LPS-induced activation of TLR4/NF-κB p65 pathway and inflammation in mice by inhibiting the expression of CD14. Acta Pharmacologica Sinica, 2021, 42(1): 88-96.

[19] Fu Y, Jie J, Lei L, Liu M, Wang J, Lei L, Liu H. Exploring the destructive synergy between IL-33 and Suilysin hemolysis on blood-brain barrier stability. Microbiol Spectr., 2024, 12(8. e0061224

[20] Gao T, Tan Y, Wang Y, Yuan F, Liu Z, Yang K, Liu W, Guo R, Li C, Tian Y, Zhou D. Theaflavin ameliorates Streptococcus suis-induced infection in vitro and in vivo. International Journal of Molecular Sciences, 2023, 24(8. 7442

[21] Gilbert RJ. Inactivation and activity of cholesterol-dependent cytolysins: What structural studies tell us. Structure, 2005, 13(8): 1097-1106.

[22] Gottschalk M, Xu J, Calzas C, Segura M. Streptococcus suis: A new emerging or an old neglected zoonotic pathogen?. Future Microbiology, 2010, 5(3): 371-391.

[23] Grynkiewicz G, Demchuk OMNew Perspectives for Fisetin. Front Chem., 2019, 7: 697.

[24] Guan M, Zhu D, Wei J, He Z, Xiong LT, Zeng Y, Song G, Deng X, Cui ZN. Design and synthesis of aryl amide derivatives containing thiazole as type III secretion system inhibitors against Pseudomonas aeruginosa. Journal of Agricultural and Food Chemistry, 2024, 72(31): 17210-17218.

[25] Haas B, Grenier D. Understanding the virulence of Streptococcus suis: A veterinary, medical, and economic challenge. Medical Malpractice & Infection, 2018, 48(3): 159-166.

[26] Heras B, Scanlon MJ, Martin JL. Targeting virulence not viability in the search for future antibacterials. British Journal of Clinical Pharmacology, 2015, 79(2): 208-215.

[27] Hosseini A, Razavi BM, Banach M, Hosseinzadeh H. Quercetin and metabolic syndrome: A review. Phytotherapy Research, 2021, 35(10): 5352-5364.

[28] Imperi F, Chen W, Smani Y. Editorial: Antivirulence drugs against bacterial infections. Frontiers in Microbiology, 2021, 12. 690672

[29] Jin X, Liu MY, Zhang DF, Zhong X, Du K, Qian P, Yao WF, Gao H, Wei MJ. Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation by suppressing the NLRP3 inflammasome and TLR4/NF-κB signaling pathway. CNS Neuroscience & Therapeutics, 2019, 25(5): 575-590.

[30] Johnson BK, Abramovitch RB. Small molecules that sabotage bacterial virulence. Trends in Pharmacological Sciences, 2017, 38(4): 339-362.

[31] Johnstone BA, Joseph R, Christie MP, Morton CJ, McGuiness C, Walsh JC, Böcking T, Tweten RK, Parker MW. Cholesterol-dependent cytolysins: The outstanding questions. IUBMB Life, 2022, 74(12): 1169-1179.

[32] Jomova K, Alomar SY, Valko R, Liska J, Nepovimova E, Kuca K, Valko M. Flavonoids and their role in oxidative stress, inflammation, and human diseases. Chemico-Biological Interactions, 2025, 413. 111489

[33] Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nature Reviews Microbiology, 2008, 6(4): 288-301.

[34] Katz L, Baltz RH. Natural product discovery: Past, present, and future. Journal of Industrial Microbiology and Biotechnology, 2016, 43(2–3): 155-176.

[35] Kerdsin A. Human Streptococcus suis infections in Thailand: Epidemiology, clinical features, genotypes, and susceptibility. Tropical Medicine and Infectious Disease, 2022, 7(11. 359

[36] Kofujita H, Ota M, Takahashi K, Kawai Y, Hayashi Y. A diterpene quinone from the bark of Cryptomeria japonica. Phytochemistry, 2002, 61(8): 895-898.

[37] Králová N, Fittipaldi N, Zouharová M, Nedbalcová K, Matiašková K, Gebauer J, Kulich P, Šimek B, Matiašovic J. Streptococcus suis strains with novel and previously undescribed capsular loci circulate in Europe. Veterinary Microbiology, 2024, 298. 110265

[38] Leitão JH. Microbial virulence factors. International Journal of Molecular Sciences, 2020, 21(15. 5320

[39] Leung C, Dudkina NV, Lukoyanova N, Hodel AW, Farabella I, Pandurangan AP, Jahan N, Pires Damaso M, Osmanović D, Reboul CF, Dunstone MA, Andrew PW, Lonnen R, Topf M, Saibil HR, Hoogenboom BW. Stepwise visualization of membrane pore formation by suilysin, a bacterial cholesterol-dependent cytolysin. eLife, 2014, 3. e04247

[40] Li G, Lu G, Qi Z, Li H, Wang L, Wang Y, Liu B, Niu X, Deng X, Wang J. Morin attenuates Streptococcus suis pathogenicity in mice by neutralizing suilysin activity. Frontiers in Microbiology, 2017, 8. 460

[41] Li G, Wang G, Wang S, Deng Y. Ginkgetin in vitro and in vivo reduces Streptococcus suis virulence by inhibiting suilysin activity. Journal of Applied Microbiology, 2019, 127(5): 1556-1563.

[42] Li G, Shen X, Wei Y, Si X, Deng X, Wang J. Quercetin reduces Streptococcus suis virulence by inhibiting suilysin activity and inflammation. International Immunopharmacology, 2019, 69: 71-78.

[43] Li G, Wang G, Wang S, Sun M, Wen Z. Isorhamnetin attenuates Streptococcus suis virulence by inhibiting the inflammatory response. Antonie Van Leeuwenhoek, 2020, 113(2): 303-310.

[44] Li K, Lacouture S, Lewandowski E, Thibault E, Gantelet H, Gottschalk M, Fittipaldi N. Molecular characterization of Streptococcus suis isolates recovered from diseased pigs in Europe. Veterinary Research, 2024, 55(1. 117

[45] Li Y, Sun C, Yao D, Gao X, Wei X, Qi Y, Liang Y, Ye J. A review of MicroRNAs and flavonoids: New insights into plant secondary metabolism. International Journal of Biological Macromolecules, 2025, 309(Pt 1. 142518

[46] Lin L, Xu L, Lv W, Han L, Xiang Y, Fu L, Jin M, Zhou R, Chen H, Zhang A. An NLRP3 inflammasome-triggered cytokine storm contributes to Streptococcal toxic shock-like syndrome (STSLS). PLoS Pathogens, 2019, 15(6. e1007795

[47] Liu H, Zhan X, Xu G, Wang Z, Li R, Wang Y, Qin Q, Shi W, Hou X, Yang R, Wang J, Xiao X, Bai Z. Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases. Pharmacological Research, 2021, 164. 105384

[48] Liu Y, Wang H, Gao J, Wen Z, Peng L. Cryptotanshinone ameliorates the pathogenicity of Streptococcus suis by targeting suilysin and inflammation. Journal of Applied Microbiology, 2021, 130(3): 736-744.

[49] Liu P, Zhang Y, Tang H, Wang Y, Sun X. Prevalence of Streptococcus suis in pigs in China during 2000–2021: A systematic review and meta-analysis. One Health, 2023, 16. 100513

[50] Liu F, Zhang S, Erdeljan M, Zhang Y, Chen Z, Li J, Ding L, Zhang L, Sun W, Yu J, Wu J. Streptococcus suis: Epidemiology and resistance evolution of an emerging zoonotic bacteria. One Health, 2025, 21. 101098

[51] Lu H, Liu M, Lu W, Wang C, Wang G, Dong W, Wang X, Chen H, Tan C. Repurposing ellipticine hydrochloride to combat colistin-resistant extraintestinal pathogenic E. coli (ExPEC). Frontiers in Microbiology, 2020, 11. 806

[52] Lu H, Wang C, Lu W, Li X, Wu Z, Wang G, Dong W, Tan C, Liu M. Apigenin and ampicillin as combined strategy to treat severe Streptococcus suis infection. Molecules, 2021, 26(7): 1980.

[53] Lu H, Li X, Wang G, Wang C, Feng J, Lu W, Wang X, Chen H, Liu M, Tan C. Baicalein ameliorates Streptococcus suis-induced infection in vitro and in vivo. International Journal of Molecular Sciences, 2021, 22(11. 5829

[54] Ma C, Xia R, Yang S, Liu L, Zhang J, Feng K, Shang Y, Qu J, Li L, Chen N, Xu S, Zhang W, Mao J, Han J, Chen Y, Yang X, Duan Y, Fan G. Formononetin attenuates atherosclerosis by regulating interaction between KLF4 and SRA in apoE(-/-) mice. Theranostics, 2020, 10(3): 1090-1106.

[55] Niu X, Sun L, Wang G, Gao Y, Yang Y, Wang X, Wang H. Investigation of the inhibition effect and mechanism of myricetin to Suilysin by molecular modeling. Scientific Reports, 2017, 7(1): 11748.

[56] Oriol-Caballo M, Moreno-Murciano MP, López-Blanch R, Estrela JM, Obrador E. Polyphenols: Potential applications in cancer therapy. Molecular Nutrition & Food Research, 2025, 69(15. e70011

[57] Palucci I, Delogu G. Alternative therapies against Mycobacterium abscessus infections. Clinical Microbiology and Infection, 2024, 30(6): 732-737.

[58] Pereira JM, Xu S, Leong JM, Sousa S. The yin and yang of pneumolysin during pneumococcal infection. Frontiers in Immunology, 2022, 13. 878244

[59] Pohlit AM, Rocha e Silva LF, Henrique MC, Montoia A, Amorim RC, Nunomura SM, Andrade-Neto VF. Antimalarial activity of ellipticine. Phytomedicine, 2012, 19(11): 1049.

[60] Ramachandran R, Heuck AP, Tweten RK, Johnson AE. Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. Natural Structural Biology, 2022, 9(11): 823-827.

[61] Rauf A, Abu-Izneid T, Imran M, Hemeg HA, Bashir K, Aljohani ASM, Aljohani MSM, Alhumaydhi FA, Khan IN, Bin Emran T, Gondal TA, Nath N, Ahmad I, Thiruvengadam M. Therapeutic potential and molecular mechanisms of the multitargeted flavonoid fisetin. Current Topics in Medicinal Chemistry, 2023, 23(21): 2075-2096.

[62] Rossi R, Mainardi E, Vizzarri F, Corino C. Verbascoside-rich plant extracts in animal nutrition. Antioxidants, 2023, 13(1. 39

[63] Segura M. Streptococcus suis: An emerging human threat. The Journal of Infectious Diseases, 2009, 199(1): 4-6.

[64] Segura M, Fittipaldi N, Calzas C, Gottschalk M. Critical Streptococcus suis Virulence Factors: Are They All truly Critical?. Trends in Microbiology, 2017, 25(7): 585-599.

[65] Seitz M, Baums CG, Neis C, Benga L, Fulde M, Rohde M, Goethe R, Valentin-Weigand P. Subcytolytic effects of suilysin on interaction of Streptococcus suis with epithelial cells. Veterinary Microbiology, 2013, 167(3–4): 584-591.

[66] Shen X, Niu X, Li G, Deng X, Wang J. Amentoflavone Ameliorates Streptococcus suis-Induced Infection In Vitro and In Vivo. Applied and Environment Microbiology, 2018, 84(24): e01804-e1818.

[67] Shen X, Liu H, Li G, Deng X, Wang J. Silibinin attenuates Streptococcus suis serotype 2 virulence by targeting suilysin. Journal of Applied Microbiology, 2019, 126(2): 435-442.

[68] Silva LN, Zimmer KR, Macedo AJ, Trentin DS. Plant natural products targeting bacterial virulence factors. Chemical Reviews, 2016, 116(16): 9162-9236.

[69] Sun R, Xu D, Wei Q, Zhang B, Aa J, Wang G, Xie Y. Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model. Biomedicine & Pharmacotherapy, 2020, 123. 109721

[70] Susilawathi NM, Tarini NMA, Fatmawati NND, Mayura PIB, Suryapraba AAA, Subrata M, Sudewi AAR, Mahardika GN. Streptococcus suis-associated meningitis, Bali, Indonesia, 2014–2017. Emerging Infectious Diseases, 2019, 25(12): 2235-2242.

[71] Takemoto M, Takemoto H. Synthesis of theaflavins and their functions. Molecules, 2018, 23(4): 918.

[72] Tenenbaum T, Asmat TM, Seitz M, Schroten H, Schwerk C. Biological activities of suilysin: Role in Streptococcus suis pathogenesis. Future Microbiology, 2016, 11: 941-954.

[73] Tilley SJ, Orlova EV, Gilbert RJ, Andrew PW, Saibil HR. Structural basis of pore formation by the bacterial toxin pneumolysin. Cell, 2005, 121(2): 247-256.

[74] Tram G, Jennings MP, Blackall PJ, Atack JM. Streptococcus suis pathogenesis-A diverse array of virulence factors for a zoonotic lifestyle. Advances in Microbial Physiology, 2021, 78: 217-257.

[75] Tweten RK. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infection and Immunity, 2005, 73(10): 6199-6209.

[76] Uruén C, García C, Fraile L, Tommassen J, Arenas J. How Streptococcus suis escapes antibiotic treatments. Veterinary Research, 2022, 53(1): 91.

[77] Varela NP, Gadbois P, Thibault C, Gottschalk M, Dick P, Wilson J. Antimicrobial resistance and prudent drug use for Streptococcus suis. Animal Health Research Reviews, 2013, 14(1): 68-77.

[78] Vollmannová A, Bojňanská T, Musilová J, Lidiková J, Cifrová M. Quercetin as one of the most abundant represented biological valuable plant components with remarkable chemoprotective effects - A review. Heliyon, 2024, 10(12. e33342

[79] Wang X, Dong J, Dai X, Zhang Y, Wang J, Li H, Lu C, Tan W, Gao X, Deng X, Bu S, Niu X. Silibinin in vitro protects A549 cells from Staphylococcus aureus-mediated injury and in vivo alleviates the lung injury of staphylococcal pneumonia. Planta Medica, 2013, 79(2): 110-115.

[80] Wang Y, Lu P, Zhang W, Du Q, Tang J, Wang H, Lu J, Hu R. GEN-27, a newly synthetic isoflavonoid, inhibits the proliferation of colon cancer cells in inflammation microenvironment by suppressing NF-κB pathway. Mediators of Inflammation, 2016, 2016. 2853040

[81] Wang G, Liu H, Liu Y, Li H, Li Z, Shao G, Lv X. Formononetin alleviates Streptococcus suis infection by targeting suilysin. Microbial Pathogenesis, 2020, 147. 104388

[82] Wang G, Gao Y, Wu X, Gao X, Zhang M, Liu H, Fang T. Inhibitory effect of Piceatannol on Streptococcus suis infection both in vitro and in vivo. Frontiers in Microbiology, 2020, 11. 593588

[83] Wang C, Lu H, Liu M, Wang G, Li X, Lu W, Dong W, Wang X, Chen H, Tan C. Effective Antibacterial and Antihemolysin Activities of Ellipticine Hydrochloride against Streptococcus suis in a Mouse Model. Applied and Environment Microbiology, 2021, 87(10): e03165-e3220.

[84] Wang G, Gao Y, Xu X, Zhang P, Wang J, Li G, Lv Q, Niu X, Liu H. Mode of action and structural modeling of the interaction of formononetin with suilysin. Journal of Applied Microbiology, 2021, 131(4): 2010-2018.

[85] Wang JY, Jiang MW, Li MY, Zhang ZH, Xing Y, Ri M, Jin CH, Xu GH, Piao LX, Jin HL, Ma J, Jin Y, Zuo HX, Jin X. Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation. Journal of Nutritional Biochemistry, 2022, 100. 108899

[86] Wang H, Fan Q, Wang Y, Yi L, Wang Y. Rethinking the control of Streptococcus suis infection: Biofilm formation. Veterinary Microbiology, 2024, 290. 110005

[87] Wei Z, Li R, Zhang A, He H, Hua Y, Xia J, Cai X, Chen H, Jin M. Characterization of Streptococcus suis isolates from the diseased pigs in China between 2003 and 2007. Veterinary Microbiology, 2009, 137(1–2): 196-201.

[88] Weis S, Palmer M. Streptolysin o: The C-terminal, tryptophan-rich domain carries functional sites for both membrane binding and self-interaction but not for stable oligomerization. Biochimica Et Biophysica Acta, 2001, 1510(1–2): 292-299.

[89] Wertheim HF, Nguyen HN, Taylor W, Lien TT, Ngo HT, Nguyen TQ, Nguyen BN, Nguyen HH, Nguyen HM, Nguyen CT, Dao TT, Nguyen TV, Fox A, Farrar J, Schultsz C, Nguyen HD, Nguyen KV, Horby P. Streptococcus suis, an important cause of adult bacterial meningitis in northern Vietnam. PLoS ONE, 2009, 4(6. e5973

[90] Witzenrath M, Gutbier B, Hocke AC, Schmeck B, Hippenstiel S, Berger K, Mitchell TJ, de los Toyos JR, Rosseau S, Suttorp N, Schütte H. Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia. Critical Care Medicine, 2006, 34(7): 1947-1954.

[91] Wu SC, Liu F, Zhu K, Shen JZ. Natural products that target virulence factors in antibiotic-resistant Staphylococcus aureus. Journal of Agricultural and Food Chemistry, 2019, 67(48): 13195-13211.

[92] Wu MC, Doan TD, Lee JW, Lo YT, Wu HC, Chu CY. Recombinant suilysin of Streptococcus suis enhances the protective efficacy of an engineered Pasteurella multocida toxin protein. Research in Veterinary Science, 2022, 151: 175-183.

[93] Wu L, Qian C, Zhang W, Shi M, Chen X, Wang Y, Lin F. Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways. Phytomedicine, 2023, 116. 154846

[94] Xie S, Zhang Y, Xu L, Li S, Shen X, Li L, Deng X, Zhou Y. Acacetin attenuates Streptococcus suis virulence by simultaneously targeting suilysin and inflammation. Microbial Pathogenesis, 2022, 162. 105354

[95] Xiong X, Tang N, Lai X, Zhang J, Wen W, Li X, Li A, Wu Y, Liu Z. Insights into amentoflavone: A natural multifunctional biflavonoid. Frontiers in Pharmacology, 2021, 12. 768708

[96] Xu L, Huang B, Du H, Zhang XC, Xu J, Li X, Rao Z. Crystal structure of cytotoxin protein suilysin from Streptococcus suis. Protein & CeLl, 2010, 1(1): 96-105.

[97] Yang Y, Zhao Y, Zhang Q, Jin M. Advances in research on the efficacy of traditional Chinese herbal medicine in combating African swine fever. Animal Diseases, 2024, 4(1): 19.

[98] Yu R, Xu Y, Schwarz S, Shang Y, Yuan X, Zhang Y, Li D, Du XD. erm(T)-Mediated Macrolide-Lincosamide Resistance in Streptococcus suis. Microbiol Spectr., 2022, 10(1. e0165721

[99] Zappavigna S, Vanacore D, Lama S, Potenza N, Russo A, Ferranti P, Dallio M, Federico A, Loguercio C, Sperlongano P, Caraglia M, Stiuso P. Silybin-induced apoptosis occurs in parallel to the increase of ceramides synthesis and miRNAs secretion in human hepatocarcinoma cells. International Journal of Molecular Sciences, 2019, 20(9): 2190.

[100] Zhang Y, Zong B, Wang X, Zhu Y, Hu L, Li P, Zhang A, Chen H, Liu M, Tan C. Fisetin lowers Streptococcus suis serotype 2 pathogenicity in mice by inhibiting the hemolytic activity of suilysin. Frontiers in Microbiology, 2018, 9: 1723.

[101] Zhang L, Liu J, Geng T. Ginkgetin aglycone attenuates the apoptosis and inflammation response through nuclear factor-kB signaling pathway in ischemic-reperfusion injury. Journal of Cellular Biochemistry, 2019, 120(5): 8078-8085.

[102] Zhang L, Song J, Kong L, Yuan T, Li W, Zhang W, Hou B, Lu Y, Du G. The strategies and techniques of drug discovery from natural products. Pharmacology & Therapeutics, 2020, 216. 107686

[103] Zhao X, Li H, Wang J, Guo Y, Liu B, Deng X, Niu X. Verbascoside alleviates pneumococcal pneumonia by reducing pneumolysin oligomers. Molecular Pharmacology, 2016, 89(3): 376-387.

[104] Zhao X, Liu B, Liu S, Wang L, Wang J. Anticytotoxin effects of amentoflavone to pneumolysin. Biological & Pharmaceutical Bulletin, 2017, 40(1): 61-67.

[105] Zhao Y, Wang S, Pan J, Ma K. Verbascoside: A neuroprotective phenylethanoid glycosides with anti-depressive properties. Phytomedicine, 2023, 120. 155027

[106] Zheng X, Kadir A, Zheng G, Jin P, Qin D, Maiwulanjiang M, Aisa HA, Yao G. Antiproliferative abietane quinone diterpenoids from the roots of Salvia deserta. Bioorganic Chemistry, 2020, 104. 104261

[107] Zhu B, Ni Y, Gong Y, Kang X, Guo H, Liu X, Li J, Wang L. Formononetin ameliorates ferroptosis-associated fibrosis in renal tubular epithelial cells and in mice with chronic kidney disease by suppressing the Smad3/ATF3/SLC7A11 signaling. Life Sciences, 2023, 315. 121331

[108] Zhu Q, Xia F, Chen Z, Lin S, Zhang Q, Xue B, Dai W. Virulence and molecular epidemiological analysis of three human blood-borne Streptococcus suis. Heliyon, 2024, 10(21. e39978

[109] Zhu S, Li S, Wu B, Yang Z, Zhang Y, Chen J, Zhang Y, Fang L. Uncovering a cryptic Streptococcus suis endemic postoutbreak: Evidence of host switching to humans. Science of the Total Environment, 2025, 959. 178307

Funding

CARS(CARS-35)

Major Program (JD) of Hubei Province(2023BAA029)

Hubei Province Postdoctoral Unveiling and Tackling Key Problems Program(707124931)

RIGHTS & PERMISSIONS

The Author(s)